Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
6.85
-0.07 (-1.01%)
Nov 17, 2026, 2:46 PM EST - Market open

Envoy Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.230.240.230.320.240.31
Revenue Growth
11.06%7.11%-28.80%33.33%-23.55%-
Cost of Revenue
0.860.680.740.790.50.77
Gross Profit
-0.63-0.44-0.52-0.47-0.26-0.46
Selling, General & Admin
8.679.158.568.933.472.47
Research & Development
14.412.4910.188.964.983.94
Operating Expenses
23.0821.6418.7417.898.456.41
Operating Income
-23.7-22.08-19.26-18.36-8.71-6.87
Interest Expense
--1.59-0.82---
Other Non Operating Income (Expenses)
3.040.1-0.721.77-0.13-1.8
EBT Excluding Unusual Items
-20.66-23.57-20.8-16.59-8.83-8.67
Gain (Loss) on Sale of Assets
------0
Other Unusual Items
-0.19-0.19--13.33-7.09-
Pretax Income
-20.85-23.76-20.8-29.92-15.92-8.68
Net Income
-20.85-23.76-20.8-29.92-15.92-8.68
Preferred Dividends & Other Adjustments
5.14.917.181.35--
Net Income to Common
-25.95-28.66-27.97-31.27-15.92-8.68
Net Income Growth
------
Shares Outstanding (Basic)
822111
Shares Outstanding (Diluted)
822111
Shares Change
264.88%23.78%52.83%21.46%-0.04%-
EPS (Basic)
-3.39-12.32-14.89-25.43-15.73-8.57
EPS (Diluted)
-3.39-12.32-14.89-25.43-15.73-8.57
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-22.44-18.38-18.93-17.24-9.02-7.06
Free Cash Flow Per Share
-2.93-7.90-10.07-14.03-8.91-6.97
Gross Margin
-270.56%-183.82%-229.78%-149.68%-110.13%-148.06%
Operating Margin
-10261.04%-9161.83%-8558.22%-5809.81%-3673.42%-2216.45%
Profit Margin
-11233.77%-11892.95%-12432.44%-9895.89%-6718.56%-2798.39%
Free Cash Flow Margin
-9712.99%-7626.56%-8412.89%-5456.96%-3807.17%-2277.74%
EBITDA
-23.4-21.78-19.08-18.23-8.63-6.8
D&A For EBITDA
0.30.30.170.130.080.07
EBIT
-23.7-22.08-19.26-18.36-8.71-6.87
SEC Filings: 10-K · 10-Q